Catalyst Pharmaceuticals (CPRX)
(Real Time Quote from BATS)
$14.30 USD
-0.01 (-0.07%)
Updated Dec 8, 2023 02:46 PM ET
3-Hold of 5 3
B Value A Growth B Momentum A VGM
Industry / Sector Report
Industry : Medical - Drugs
Zacks Industry Rank
Top 29% (72 out of 251)Zacks Sector Rank
Top 19% (3 out of 16)Recommendations and Estimates
Company | Industry | SP500 | |
---|---|---|---|
Average Recommendation (1=Buy, 5=Sell) | 1.40 | 1.52 | 9.99 |
Current Quarter Estimate | 0.46 | -2.04 | 58.00 |
Year Ago Quarter Estimate | 0.22 | -0.59 | 50.35 |
Next Quarter Estimate | 0.54 | -2.00 | 59.00 |
Next Year Estimate | 2.39 | 6.92 | 250.00 |
Growth Rates
Company | Industry | SP500 | |
---|---|---|---|
This Year | 125.33 | 13.60 | 14.24 |
Next Year | 41.42 | 14.40 | 11.11 |
Last 5 Years | NA | 6.20 | 9.00 |
Next 5 Years | NA | 21.90 | NA |
Financials
Company | Industry | |
---|---|---|
Price/Earnings (TTM) | 25.10 | -5.88 |
Price/Book (MRQ) | 4.38 | 1.55 |
Price/Cash Flow (MRFY) | 17.66 | 9.04 |
Dividend Yield | 0.00% | 0.00% |
Net Profit Margin (TTM) | 17.81% | -95.53% |
Return on Equity (TTM) | 19.32% | -57.32% |
Debt to Equity (MRQ) | 0.00 | 0.00 |
MRQ = Most Recent Quarter
TTM = Trailing Twelve Months
MRFY = Most Recent Fiscal Year
Note: Company and S&P 500 ratios relating to share price calculated daily; all others calculated weekly or in accordance with company earnings announcement. Industry medians calculated weekly.